News
Chardan Capital Maintains Buy on Dyne Therapeutics, Maintains $31 Price Target
6 May 24
News, Price Target, Analyst Ratings
Oppenheimer Reiterates Outperform on Dyne Therapeutics, Maintains $47 Price Target
6 May 24
News, Price Target, Reiteration, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Dyne Therapeutics, Maintains $36 Price Target
3 May 24
News, Price Target, Reiteration, Analyst Ratings
Morgan Stanley Initiates Coverage On Dyne Therapeutics with Overweight Rating, Announces Price Target of $40
30 Apr 24
News, Price Target, Initiation, Analyst Ratings
Oppenheimer Reiterates Outperform on Dyne Therapeutics, Maintains $47 Price Target
26 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
25 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Aehr Test Systems Reports Preliminary Results, Joins Dyne Therapeutics, United Airlines And Other Big Stocks Moving Lower On Monday
25 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Neuromuscular Focused-Avidity Biosciences Has 'Complete Package' - Analyst Predicts Stellar 142% Stock Surge
14 Mar 24
Analyst Color, Biotech, Equities, News, Health Care, Price Target, Initiation, Analyst Ratings, Trading Ideas, General
Chardan Capital Maintains Buy Rating for Dyne Therapeutics: Here's What You Need To Know
8 Mar 24
Analyst Ratings
Chardan Capital Maintains Buy on Dyne Therapeutics, Raises Price Target to $31
8 Mar 24
News, Price Target, Analyst Ratings
Guggenheim Maintains Buy on Dyne Therapeutics, Raises Price Target to $37
7 Mar 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Dyne Therapeutics, Maintains $36 Price Target
6 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Piper Sandler Maintains Overweight Rating for Dyne Therapeutics: Here's What You Need To Know
6 Mar 24
Analyst Ratings
Stifel Maintains Buy on Dyne Therapeutics, Raises Price Target to $41
6 Mar 24
News, Price Target, Analyst Ratings
Piper Sandler Maintains Overweight on Dyne Therapeutics, Raises Price Target to $29
6 Mar 24
News, Price Target, Analyst Ratings
Oppenheimer Reiterates Outperform on Dyne Therapeutics, Raises Price Target to $47
5 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Recap: Dyne Therapeutics Q4 Earnings
5 Mar 24
Earnings
Dyne Therapeutics Q4 EPS $(1.09) Misses $(0.92) Estimate, Cash Balance of $123.1M
5 Mar 24
Earnings, News
Cooper Companies Reports Upbeat Results, Joins Dell, NetApp, Tidewater And Other Big Stocks Moving Higher On Friday
1 Mar 24
News, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Top 4 Health Care Stocks You May Want To Dump In February
15 Feb 24
News, Penny Stocks, Short Ideas, Small Cap, Pre-Market Outlook, Markets, Trading Ideas
Press releases
Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
2 May 24
Earnings, Press Releases
Dyne Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed President and Chief Executive Officer
27 Mar 24
Markets, Press Releases
Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium
27 Mar 24
News, Press Releases
Dyne Therapeutics Announces CEO Transition
25 Mar 24
News, Management, Press Releases
Dyne Therapeutics to Present at Stifel 2024 Virtual CNS Days
13 Mar 24
News, Press Releases
Dyne Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
5 Mar 24
Earnings, Health Care, Press Releases
Dyne Therapeutics Announces Upcoming Presentations on Initial Clinical Data From its ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients at the 2024 Muscular Dystrophy Association Clinical & Scientific Conference
14 Feb 24
News, Health Care, Press Releases